Adv Ther News Today

Here's how to enjoy winter without being snowed under with tissues!

Embrace the Winter Warrior within with the Adcock Ingram Range, featuring Panado®, Cepacol®, Compral®, and ViralGuard™.

Results showed treatment with dapagliflozin 10 mg was associated with clinically meaningful attenuations in eGFR slope in patients with CKD and urinary albumin-to-creatinine ratio < 200 mg/g.

Innovative investigational device designed for Left Atrial Appendage Elimination to reduce the risk of stroke in patients with non-valvular atrial fibrillation Strengthens position in high-growth...

Did you know that the science itself on the flu vaccine shows it does virtually nothing to protect ...

NICE Recommends Astellas’ EVRENZO▼™ (roxadustat) For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease EVRENZOTM (roxadustat) is the first hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor to be recommended by NICE1Over 75,000 adults in England and Wales living with...

SABINA programme demonstrates SABA reliever overuse is a global issue in asthma management     Real-world evidence analysis of SABA use in over 1 million patients with asthma consistently showed three or more SABA inhalers a year was associated with increased risk of severe asthma exacerbations    &nb...

Press release content from Business Wire. The AP news staff was not involved in its creation.

ABBVie today announced top-line results from the Phase 3b Heads Up study showing that upadacitinib achieved superiority to dupilumab for the primary endpoint, the proportion of patients with at least a 75 percent improvement in the Eczema Area Severity Index at week 16, in adults with moderate to severe atopic dermatitis. 1 Of patients treated with upadacitinib, 71 percent achieved EASI 75 at week 16 compared to 61 … ABBVie (NYSE: ABBV) today announced top-line results from the Phase 3b Heads...